Reported covered position: Director, Federal Legislative Affairs
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
VALID Act of 2021
Client: MEMORIAL SLOAN-KETTERING CANCER CENTER · Firm: MEMORIAL SLOAN KETTERING CANCER CENTER
Telehealth (extension of waivers/make permanent) ONC information blocking rule FEMA covid $ Laboratory Developed Tests; S. 2209 Medicaid access/network adequacy
VALID Act of 2021
Client: MEMORIAL SLOAN-KETTERING CANCER CENTER · Firm: MEMORIAL SLOAN KETTERING CANCER CENTER
Telehealth (extension of waivers/make permanent) FEMA covid $ Laboratory Developed Tests; S. 2209 ARPA-H funding Access to care J1-visa issues Home health care
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2026 · third_quarter · Q3
site neutral payment policy NIH funding Community benefit
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2026 · second_quarter · Q2
Source: Senate LDA
VALID Act of 2021
Client: MEMORIAL SLOAN-KETTERING CANCER CENTER · Firm: MEMORIAL SLOAN KETTERING CANCER CENTER
Telehealth (extension of waivers/make permanent) FEMA covid $ Laboratory Developed Tests; S. 2209 ARPA-H funding Access to care Home health care statutory paygo
VALID Act of 2021
Client: MEMORIAL SLOAN-KETTERING CANCER CENTER · Firm: MEMORIAL SLOAN KETTERING CANCER CENTER
Telehealth (extension of waivers/make permanent) ONC information blocking rule FEMA covid $ Laboratory Developed Tests; S. 2209
TREAT Act
Client: MEMORIAL SLOAN-KETTERING CANCER CENTER · Firm: MEMORIAL SLOAN KETTERING CANCER CENTER
Telehealth (extension of waivers/make permanent) TREAT Act. HR 708 NIH funding health equity Provider Relief Fund - phase 3
CARES Act
Client: MEMORIAL SLOAN-KETTERING CANCER CENTER · Firm: MEMORIAL SLOAN KETTERING CANCER CENTER
Radiation Oncology Model HR 748, CARES Act Drug shortages
Medicare Access to Radiology Care Act of 2017
Client: MEMORIAL SLOAN-KETTERING CANCER CENTER · Firm: MEMORIAL SLOAN KETTERING CANCER CENTER
IV opioid shortages CAR T-cell reimbursement Site neutral HR 1904, Medicare Access to Radiology Care Act of 2017 Next Generation Sequencing tests
Preserving Employee Wellness Programs Act
Client: MEMORIAL SLOAN-KETTERING CANCER CENTER · Firm: MEMORIAL SLOAN KETTERING CANCER CENTER
HR 1313, the American Health Care Act
American Health Care Act of 2017
Client: MEMORIAL SLOAN-KETTERING CANCER CENTER · Firm: MEMORIAL SLOAN KETTERING CANCER CENTER
HR 1628, the American Health Care Act - provisions related to pre-existing conditions and access to care Better Care Reconciliation Act - provisions related to pre-existing conditions and access to care President's Budget - provisions related to funding for the National Institutes of Health; cuts to the indirect cost rate S. 769/HR 1904, Medicare Access to Radiology Care of 2017 Laboratory Developed Tests
Medicare Access to Radiology Care Act of 2017
Client: MEMORIAL SLOAN-KETTERING CANCER CENTER · Firm: MEMORIAL SLOAN KETTERING CANCER CENTER
HR 1628, the American Health Care Act - provisions related to pre-existing conditions and access to care Better Care Reconciliation Act - provisions related to pre-existing conditions and access to care President's Budget - provisions related to funding for the National Institutes of Health; cuts to the indirect cost rate S. 769/HR 1904, Medicare Access to Radiology Care of 2017 Laboratory Developed Tests
Medicare Access to Radiology Care Act of 2017
Client: MEMORIAL SLOAN-KETTERING CANCER CENTER · Firm: MEMORIAL SLOAN KETTERING CANCER CENTER
Telemedicine NIH funding Healthcare Reform HR1904, the Medicare Access to Radiology Care Act of 2017 Executive Order on DACA CAR-T reimbursement
Medicare Access to Radiology Care Act of 2017
Client: MEMORIAL SLOAN-KETTERING CANCER CENTER · Firm: MEMORIAL SLOAN KETTERING CANCER CENTER
CAR-T reimbursement HR 1904, the Medicare Access to Radiology Care Act of 2017 Medicare reimbursement for telemedicine services
Medicare Access to Radiology Care Act of 2017
Client: MEMORIAL SLOAN-KETTERING CANCER CENTER · Firm: MEMORIAL SLOAN KETTERING CANCER CENTER
HR 1628, the American Health Care Act - provisions related to pre-existing conditions and access to care Better Care Reconciliation Act - provisions related to pre-existing conditions and access to care President's Budget - provisions related to funding for the National Institutes of Health; cuts to the indirect cost rate S. 769/HR 1904, Medicare Access to Radiology Care of 2017 Laboratory Developed Tests
site neutral payment policy NIH funding FEMA funding Community benefit
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2026 · first_quarter · Q1
site neutral payment policy NIH funding Indirect Cost Rate FEMA funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2025 · fourth_quarter · Q4
site neutral payment policy NIH funding Indirect Cost Rate Restoration of the PBTC H-1B visa proclamation FEMA funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2025 · third_quarter · Q3
site neutral payment policy NIH funding Indirect Cost Rate CDMRP funding Medicaid cuts Restoration of the PBTC
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2025 · second_quarter · Q2
site neutral payment policy NIH funding Indirect Cost Rate CDMRP funding Medicaid cuts
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2025 · first_quarter · Q1
site neutral payment policy NIH funding Indirect Cost Rate CDMRP funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2024 · fourth_quarter · Q4
Site neutral payments AViDD center funding glioblastoma funding NIH funding NIH reorganization/F&A costs Medicare telehealthlist FEMA funding Anthem negotiations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2024 · third_quarter · Q3
Site neutral payments AViDD center funding glioblastoma funding NIH funding NIH reorganization/F&A costs Medicare telehealthlist
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2024 · second_quarter · Q2
Site neutral AViDD center funding glioblastoma funding BIOSECURE Act NIH funding NIH reorganization/F&A costs Telehealth
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2024 · first_quarter · Q1
Site neutral FEMA reimbursement AViDD center funding laboratory developed tests glioblastoma funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2023 · fourth_quarter · Q4
Site neutral FEMA reimbursement AViDD center funding laboratory developed tests glioblastoma funding
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2023 · third_quarter · Q3
Site neutral FEMA reimbursement laboratory developed tests glioblastoma funding alternative financing programs
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2023 · second_quarter · Q2
Site neutral FEMA reimbursement Debt ceiling Workforce issues appropriations
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2023 · first_quarter · Q1
ARPA-H funding Appropriations FEMA reimbursement Site neutral Debt ceiling Medicare Advantage
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2022 · fourth_quarter · Q4
Telehealth (extension of waivers/make permanent) FEMA covid $ Laboratory Developed Tests; S. 2209 ARPA-H funding Access to care Home health care statutory paygo
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2022 · third_quarter · Q3
Telehealth (extension of waivers/make permanent) FEMA covid $ Laboratory Developed Tests; S. 2209 ARPA-H funding Access to care J1-visa issues Home health care
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2022 · second_quarter · Q2
Telehealth (extension of waivers/make permanent) ONC information blocking rule FEMA covid $ Laboratory Developed Tests; S. 2209
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2022 · first_quarter · Q1
Telehealth (extension of waivers/make permanent) ONC information blocking rule FEMA covid $ Laboratory Developed Tests; S. 2209 Medicaid access/network adequacy
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2021 · fourth_quarter · Q4
Telehealth (extension of waivers/make permanent) Drug pricing health equity ONC information blocking rule FEMA covid $
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2021 · third_quarter · Q3
Telehealth (extension of waivers/make permanent) Drug pricing health equity Provider Relief Fund - phase 3 ONC information blocking rule
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2021 · second_quarter · Q2
Telehealth (extension of waivers/make permanent) Drug pricing health equity Provider Relief Fund - phase 3 ONC information blocking rule
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2021 · first_quarter · Q1
Telehealth (extension of waivers/make permanent) TREAT Act. HR 708 NIH funding health equity Provider Relief Fund - phase 3
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2020 · fourth_quarter · Q4
Provider Relief Fund telehealth/TREAT Act Increased NIH funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2020 · third_quarter · Q3
Provider Relief Fund/accelerated payment loan forgiveness and change of terms telehealth/TREAT Act RISE Act/increased NIH funding Rad Onc Model
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2020 · second_quarter · Q2
HEROES Act Provider Relief Fund/accelerated payment loan forgiveness and change of terms telehealth RISE Act/increased NIH funding
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2020 · first_quarter · Q1
Radiation Oncology Model HR 748, CARES Act Drug shortages
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2019 · fourth_quarter · Q4
Site Neutral CAR T reimbursement Drug shortages Drug pricing Privacy RadOnc proposed model
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2019 · third_quarter · Q3
Site Neutral CAR T reimbursement Drug shortages Drug pricing Privacy
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2019 · second_quarter · Q2
Site Neutral CAR T reimbursement Drug shortages VALID Act - in vitro diagnostics Drug pricing Privacy
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2019 · first_quarter · Q1
Site Neutral CAR T reimbursement Drug shortages VALID Act - in vitro diagnostics
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2018 · fourth_quarter · Q4
CAR T reimbursement and access site neutral payment NIH funding Diagnostic Accuracy and Innovation Act (IVDs and LDTs) drug shortages
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2018 · third_quarter · Q3
CAR T reimbursement and access site neutral payment IPPS, PFS, and OPPS rules NIH funding Diagnostic Accuracy and Innovation Act (IVDs and LDTs) drug shortages
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2018 · second_quarter · Q2
IV opioid shortages CAR T-cell reimbursement Site neutral HR 1904, Medicare Access to Radiology Care Act of 2017 Next Generation Sequencing tests
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2018 · first_quarter · 1A
Medicare coding and payment for advanced diagnostic laboratory tests, including NGS testing Medicare coverage for NGS testing Site neutral CAR-T reimbursement Injectable Opioid shortage Opioids - impact of potential legislation (generally) on cancer care
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2018 · first_quarter · Q1
Medicare coding and payment for advanced diagnostic laboratory tests, including NGS testing Medicare coverage for NGS testing Site neutral CAR-T reimbursement Injectable Opioid shortage Opioids - impact of potential legislation (generally) on cancer care
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2017 · fourth_quarter · Q4
IV solution shortage Medicare reimbursement for CAR-T therapy, radiology assistants, and Next Generation Sequencing NCD tax reform telemedicine
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2017 · third_quarter · Q3
CAR-T reimbursement HR 1904, the Medicare Access to Radiology Care Act of 2017 Medicare reimbursement for telemedicine services
DACA Executive Order
Telemedicine NIH funding Healthcare Reform HR1904, the Medicare Access to Radiology Care Act of 2017 Executive Order on DACA CAR-T reimbursement
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2017 · second_quarter · Q2
HR 1628, the American Health Care Act - provisions related to pre-existing conditions and access to care Better Care Reconciliation Act - provisions related to pre-existing conditions and access to care President's Budget - provisions related to funding for the National Institutes of Health; cuts to the indirect cost rate S. 769/HR 1904, Medicare Access to Radiology Care of 2017 Laboratory Developed Tests
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEMORIAL SLOAN-KETTERING CANCER CENTER via MEMORIAL SLOAN KETTERING CANCER CENTER
2017 · first_quarter · Q1
HR 1313, the American Health Care Act
Funding for NIH
H1-B restrictions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NIH funding Facilities and Administration funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE